Evidence map›Paper›PMID 8094556›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1993

A genetic approach to the generation of antibodies with enhanced catalytic activities.

S A Lesley, P A Patten, P G Schultz

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Bringing biological solutions to chemical problems.Proceedings of the National Academy of Sciences of the United States of America · 1998
    Article
  3. Review
  4. On the failure of de novo-designed peptides as biocatalysts.Proceedings of the National Academy of Sciences of the United States of America · 1996
    Review
  5. Expression studies of catalytic antibodies.Proceedings of the National Academy of Sciences of the United States of America · 1995
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

S A LesleyDepartment of Chemistry, University of California, Berkeley 94720.
P A Patten
P G Schultz
University of California, Berkeley · US

Funding

SYNTHESIS OF CATALYTIC ANTIBODIESR01AI024695 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI SCHULTZ, PETER G · 1987 to 1996
–
NIAID NIH HHS R01-AI24695
6 · The paper itself

Abstract

A hydrolytic catalytic antibody, generated against a nitrophenyl phosphonate transition state analogue, has been cloned and expressed in Escherichia coli for use as a model system to demonstrate the feasibility of using genetic selections to enhance catalytic activity. Conditions were found that permit the secretion of active recombinant antibody into the periplasm of a strain of E. coli deficient in the biotin biosynthetic genes (delta bio-gal). A number of substrates were synthesized that, upon hydrolysis by the antibody, yield free biotin, which is required for cell growth. The substrates and selections can be used to identify mutants of the antibody with altered activities. This approach should be generalizable to a wide number of hydrolytic reactions including the selective cleavage of peptide, polysaccharide, phosphodiester, and ester bonds.

Indexed as

Genes, ImmunoglobulinAmino Acid SequenceAnimalsAntibodies, MonoclonalBase SequenceCloning, MolecularEscherichia coliGenetic VectorsHaptensImmunoglobulin Fab FragmentsImmunoglobulin Heavy ChainsImmunoglobulin Light ChainsImmunoglobulin Variable RegionMiceMolecular Sequence DataPlasmidsAntibodies, MonoclonalHaptensImmunoglobulin Fab FragmentsImmunoglobulin Heavy ChainsImmunoglobulin Light ChainsImmunoglobulin Variable RegionPoly ARecombinant ProteinsRNA, Messenger

Identifiers

PMID8094556
PMCPMC45833
OpenAlexW2074313457

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.